The purpose of the C3 Glomerulopathy Database is to provide physicians an online resource to upload clinical and pathological data (renal biopsies) on patients with C3 Glomerulopathies. Included under this umbrella are Dense Deposit Disease (DDD) and C3 Glomerulonephritis (C3GN). The Molecular Otolaryngology and Renal Research Laboratories (MORL)
works closely with treating physicians to provide genetic and biomarker data on patients to facilitate state-of-the-art clinical care. As part of this service, the MORL
also completes comprehensive studies of the genetics and complement cascade in these patients. These studies are undertaken as part of our overriding goal, which is to develop an effective treatment for these diseases.